Dysregulated lncRNAs in CAD patients have functional interactions with Wnt/β-catenin, NF-κB, TGF-βR1/Smad, JAK/STAT, PTEN/AKT, and mTOR signaling pathways. This evidence concerns the gene MTOR and coronary artery disorder.